Picture of Hanmi Pharm logo

128940 — Hanmi Pharm News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Brief: Marinomed Biotech Signs New Agreement For Carragelose In South Korea

April 12 (Reuters) - MARINOMED BIOTECH AG  MARI.VI :
    * SIGNS NEW AGREEMENT FOR CARRAGELOSE IN SOUTH KOREA
    * CARRAGELOSE, SHOWN TO EFFECTIVELY INACTIVATE SARS-COV-2
WILDTYPE
AND COMMON VARIANTS, IS CURRENTLY AVAILABLE IN MORE THAN 40
COUNTRIES WORLDWIDE
    * MARINOMED WINS HANMI PHARMACEUTICAL CO., LTD. AS PARTNER
FOR
DISTRIBUTION OF CARRAGELOSE NASAL

Source text for Eikon:  ID:nEQzwMsDa 
Further company coverage:  MARI.VI 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Hanmi Pharm

See all news